SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-16-006904
Filing Date
2016-08-18
Accepted
2016-08-18 16:15:20
Documents
5
Period of Report
2016-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fpmi8k_aug152016.htm 8-K 28755
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION. ex3-1.htm EX-3.1 830
3 fpmi8k_aug1520161.jpg GRAPHIC 1229
4 fpmi8k_aug1520160.jpg GRAPHIC 1229
5 fpmi_01.jpg GRAPHIC 196558
  Complete submission text file 0001415889-16-006904.txt   305467
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-147193 | Film No.: 161841103
SIC: 2835 In Vitro & In Vivo Diagnostic Substances